CoverageForm 410-K10-Q8-K13D13G13F

Gall Matthew

CIK 0001816194
Chief Financial Officer

Filings

11

Latest May 5, 2026

Issuers covered

3

Showing

11 of 11

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Gall Matthew. Track record appears once open-market purchases or sales reach the +30 day horizon.

Issuers

Companies where Gall Matthew has filed

TickerIssuerFilingsLast filed
ITOSIteos Therapeutics, Inc.8Aug 29, 2025
KLRSKalaris Therapeutics, Inc.2Mar 20, 2026
TNGXTango Therapeutics, Inc.1May 5, 2026

All filings

11 Form 4 / 4-A filings, newest first

Sign in to download
Filed Top transactionSharesPriceValue